{"id":"W2171492921","doi":"10.1053/j.gastro.2012.04.046","title":"Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children","year":2012,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":302,"is_retracted":false,"has_abstract":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Abbott Laboratories","keywords":"Medicine; Adalimumab; Dosing; Adverse effect; Internal medicine; Infliximab; Crohn's disease; Gastroenterology; Inflammatory bowel disease; Clinical endpoint; Clinical trial; Surgery; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001276129,0.0001184202,0.0001416523,0.00004800782,0.00002629509,0.000003779313,0.0000950012,0.00005693521,0.000007727353],"category_scores_gemma":[0.00006302432,0.0001221797,0.00005401107,0.00001894866,0.00005306555,0.000004947719,0.000111889,0.00003693486,0.000002096282],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009885164,"about_ca_system_score_gemma":0.00002199705,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006086389,"about_ca_topic_score_gemma":0.00003694548,"domain_scores_codex":[0.9991217,0.00006920702,0.0001922705,0.0002157803,0.0000436804,0.0003573809],"domain_scores_gemma":[0.9994732,0.000006881018,0.00005028141,0.000215726,0.00003072528,0.0002231978],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01619257,0.0001325251,0.9802221,0.00001915961,0.00004372493,0.00000441424,0.00004295506,0.0006745344,0.002201721,0.00005053009,0.0001883214,0.0002274337],"study_design_scores_gemma":[0.003073466,0.0001673102,0.996148,0.000006256221,0.00002360437,0.000008985563,0.00000485903,0.00007953571,0.0002254714,0.00001472127,0.0001760357,0.00007174738],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997805,0.00006812272,0.001292496,0.0001115469,0.00005521413,0.0004760405,0.0001716632,0.000004905716,0.00001500433],"genre_scores_gemma":[0.998693,0.00001233842,0.0004431816,0.0005300838,0.0001073081,0.00004162388,0.0001232736,0.00001673719,0.00003241061],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0159259,"threshold_uncertainty_score":0.4982343,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004997114536812087,"score_gpt":0.2274647165722178,"score_spread":0.2224676020354057,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}